Literature DB >> 326680

Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

T R Kozel.   

Abstract

The binding of cryptococcal polysaccharide to a non-encapsulated strain of Cryptococcus neoformans was studied. Binding of purified polysaccharide to the yeast was determined by inhibition of phagocytosis and by indirect immunofluorescence techniques. The ability of cryptococcal polysaccharide to prevent phagocytosis of the non-encapsulated strain appears to be directly related to adherence of polysaccharide to the yeast via specific receptors on the cell surface. Addition of varying doses of cryptococcal polysaccharide to non-encapsulated yeast cells inhibited phagocytosis only at polysaccharide concentrations at which the polysaccharide could be demonstrated on the yeast surface by immunofluorescence. Macrophages treated with cryptococcal polysaccharide had no detectable amounts of cryptococcal polysaccharide adherent to their surface, and they had a normal ability to phagocytize the yeast. Kinetic studies showed that inhibition of phagocytosis is directly related to the presence of cryptococcal polysaccharide at the yeast surface rather than to some indirect effect by the polysaccharide on serum components necessary for phagocytosis. Purified polysaccharide from C. neoformans serotypes A, B, C, and D bound to the yeast, but type III pneumococcal polysaccharide did not inhibit phagocytosis of the nonencapsulated yeast. Cryptococcal polysaccharide did not bind to cells of Candida albicans, C. pseudotropicalis, Torulopsis sp., Rhodotorula sp., or Saccharomyces cerevisiae.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326680      PMCID: PMC421494          DOI: 10.1128/iai.16.1.99-106.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.

Authors:  R D Diamond; J E May; M A Kane; M M Frank; J E Bennett
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

2.  Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.

Authors:  R D Diamond; R K Root; J E Bennett
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

3.  Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans.

Authors:  T R Kozel; J Cazin
Journal:  Mycopathol Mycol Appl       Date:  1974-10-15

4.  Immunofluorescence studies of reactions at the Cryptococcal capsule.

Authors:  M B Goren; J Warren
Journal:  J Infect Dis       Date:  1968-04       Impact factor: 5.226

5.  Phagocytosis of Cryptococcus neoformans by alveolar macrophages.

Authors:  G S Bulmer; J R Tacker
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

6.  Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.

Authors:  T R Kozel; R P Mastroianni
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Cryptococcus neoformans. 3. Inhibition of phagocytosis.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

8.  Cryptococcus neoformans. I. Nonencapsulated mutants.

Authors:  G S Bulmer; M D Sans; C M Gunn
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

9.  In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.

Authors:  T G Mitchell; L Friedman
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

10.  Intracellular fate of Cryptococcus neoformans.

Authors:  J R Tacker; F Farhi; G S Bulmer
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

View more
  50 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

2.  Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.

Authors:  Marcellene A Gates; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

3.  New fluorescence assay for the quantitation of fungi.

Authors:  T Coleman; J V Madassery; G S Kobayashi; M H Nahm; J R Little
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

4.  Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.

Authors:  C Retini; T R Kozel; D Pietrella; C Monari; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Recombinational mapping of capsule mutations in Cryptococcus neoformans.

Authors:  C N Still; E S Jacobson
Journal:  J Bacteriol       Date:  1983-10       Impact factor: 3.490

6.  Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.

Authors:  J K van de Wetering; F E J Coenjaerts; A B Vaandrager; L M G van Golde; J J Batenburg
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Genetic study of oxygen resistance and melanization in Cryptococcus neoformans.

Authors:  H S Emery; C P Shelburne; J P Bowman; P G Fallon; C A Schulz; E S Jacobson
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.

Authors:  J M Small; T G Mitchell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

Review 9.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

10.  Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.

Authors:  Z M Dong; J W Murphy
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.